Utah Medical Products, Inc. (UTMD)

NASDAQ: UTMD · IEX Real-Time Price · USD

69.91

-1.09 (-1.54%)

At close: Jul 19, 2024, 4:00 PM

69.94

+0.03 (0.04%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1995
Revenue	49.04	50.22	52.28	49.05	42.18	46.9	Upgrade
Revenue Growth (YoY)	-6.54%	-3.93%	6.58%	16.30%	-10.08%	11.68%	Upgrade
Cost of Revenue	20.08	20.19	20.09	18.14	16.63	17.44	Upgrade
Gross Profit	28.96	30.04	32.2	30.92	25.55	29.47	Upgrade
Selling, General & Admin	12.06	12.7	11.91	11.51	11.35	11.35	Upgrade
Research & Development	0.68	0.56	0.49	0.53	0.49	0.48	Upgrade
Operating Expenses	12.74	13.26	12.41	12.04	11.84	11.83	Upgrade
Operating Income	16.22	16.78	19.79	18.88	13.71	17.63	Upgrade
Other Expense / Income	-3.55	-3.31	-0.87	-0.18	-0.13	-0.25	Upgrade
Pretax Income	19.77	20.09	20.66	19.06	13.84	17.88	Upgrade
Income Tax	3.39	3.45	4.19	4.27	3.04	3.16	Upgrade
Net Income	16.38	16.64	16.47	14.79	10.8	14.73	Upgrade
Net Income Growth	-4.52%	0.98%	11.39%	36.95%	-26.68%	-20.63%	Upgrade
Shares Outstanding (Basic)	4	4	4	4	4	4	Upgrade
Shares Change	-0.28%	0.05%	-0.64%	0.29%	-2.17%	-0.35%	Upgrade
EPS (Basic)	4.51	4.58	4.53	4.05	2.95	3.96	Upgrade
EPS (Diluted)	4.50	4.57	4.52	4.04	2.94	3.94	Upgrade
EPS Growth	-4.66%	1.11%	11.88%	37.41%	-25.38%	-20.40%	Upgrade
Free Cash Flow	20.05	21.64	20.34	20.65	19.28	16.52	Upgrade
Free Cash Flow Per Share	5.54	5.96	5.61	5.66	5.29	4.44	Upgrade
Dividend Per Share	1.190	1.185	1.165	2.855	1.125	1.105	Upgrade
Dividend Growth	1.71%	1.72%	-59.19%	153.78%	1.81%	1.84%	Upgrade
Gross Margin	59.05%	59.81%	61.58%	63.03%	60.57%	62.82%	Upgrade
Operating Margin	33.07%	33.40%	37.85%	38.49%	32.50%	37.59%	Upgrade
Profit Margin	33.39%	33.12%	31.51%	30.15%	25.60%	31.40%	Upgrade
Free Cash Flow Margin	40.88%	43.09%	38.90%	42.10%	45.70%	35.21%	Upgrade
Effective Tax Rate	17.15%	17.19%	20.26%	22.42%	21.98%	17.65%	Upgrade
EBITDA	25.06	26.46	27.74	26.35	21.05	24.77	Upgrade
EBITDA Margin	51.09%	52.68%	53.06%	53.71%	49.91%	52.80%	Upgrade
Depreciation & Amortization	5.29	6.37	7.08	7.28	7.21	6.88	Upgrade
EBIT	19.77	20.09	20.66	19.06	13.84	17.88	Upgrade
EBIT Margin	40.31%	40.00%	39.52%	38.86%	32.81%	38.13%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).